how do glp-1 agonists work for diabetes Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review A Comprehensive Review of the
Description
The thyroid cancer debate has been one of the most significant GLP-1 RA-associated safety concerns
GLP-1R agonists cannot be currently recommended as targeted approaches for MASH but should be administered for their indications (T2D, obesity)
Cramon, L
60,61 Most of the available programs of pharmacovigilance are based on self-report of adverse events experienced by individuals reportedly taking the drug of interest and are designed to serve as hypothesis generating studies that trigger further evaluation to determine association or causality
PMID 21950636
